BNP Paribas Asset Management’s Horizon Therapeutics Public Limited Company Ordinary Shares HZNP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2023
Q4
Sell
-10,129
Closed -$1.17M 874
2023
Q3
$1.17M Sell
10,129
-799
-7% -$92.5K ﹤0.01% 717
2023
Q2
$1.12M Buy
10,928
+717
+7% +$73.7K ﹤0.01% 717
2023
Q1
$1.11M Sell
10,211
-673,689
-99% -$73.5M ﹤0.01% 743
2022
Q4
$77.8M Sell
683,900
-384,413
-36% -$43.7M 0.28% 90
2022
Q3
$66.1M Buy
1,068,313
+358,243
+50% +$22.2M 0.26% 87
2022
Q2
$56.6M Buy
710,070
+116,024
+20% +$9.25M 0.22% 117
2022
Q1
$62.5M Buy
594,046
+36,155
+6% +$3.8M 0.22% 106
2021
Q4
$60.1M Buy
557,891
+212,466
+62% +$22.9M 0.2% 118
2021
Q3
$37.8M Buy
345,425
+20,452
+6% +$2.24M 0.14% 183
2021
Q2
$30.4M Buy
324,973
+194,646
+149% +$18.2M 0.11% 234
2021
Q1
$12M Buy
130,327
+126,530
+3,332% +$11.6M 0.05% 377
2020
Q4
$278K Buy
+3,797
New +$278K ﹤0.01% 811